Results 181 to 190 of about 39,999 (253)

Misclassification of Hypertension Status According to Office Blood Pressure vs 24-Hour Ambulatory Blood Pressure Monitoring. [PDF]

open access: yesCJC Open
Hundemer GL   +10 more
europepmc   +1 more source

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 357-374, August 2026.
Parkinsonian disorders, including Parkinson's disease, Lewy body dementia, multiple system atrophy, and progressive supranuclear palsy, are progressive neurodegenerative conditions with no treatment options to slow disease progression. This systematic review provides an overview of evidence of disease‐modifying therapies that have been evaluated in ...
Pepijn P.N.M. Eijsvogel   +3 more
wiley   +1 more source

Contextual Factors Affecting SGLT2 Inhibitors and GLP‐1 Receptor Agonists Prescribing in Primary Care: An Application of the Consolidated Framework for Implementation Research

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 8, August 2026.
ABSTRACT Background Despite strong evidence supporting cardiovascular and kidney benefits of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) in patients with type 2 diabetes, prescribing rates remain suboptimal. The aim of this study was to assess clinicians' knowledge and comfort prescribing
Teresa M. Salgado   +7 more
wiley   +1 more source

Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes. [PDF]

open access: yesEur Heart J
Böhm M   +11 more
europepmc   +1 more source

Downstream Pathways of Dystrophin Deficiency in Duchenne Muscular Dystrophy: Implications for Muscle Degeneration and Regeneration

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 4, August 2026.
ABSTRACT Background Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dystrophy, primarily affecting skeletal muscle and leading to premature death. Although the loss of dystrophin has long been recognised as the primary cause of the disease, no definitive cure is currently available. As a consequence, therapeutic efforts
Raffaele Epis   +5 more
wiley   +1 more source

Calcium Beta‐Hydroxy‐Beta‐Methylbutyrate‐Enriched Nutritional Supplementation During Dietary Weight Loss in Adults With Obesity: A Randomized Controlled Trial

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 4, August 2026.
ABSTRACT Background Dietary and pharmacologic weight loss can reduce skeletal muscle. Whether calcium beta‐hydroxy‐beta‐methylbutyrate (CaHMB)‐enriched supplementation preserves muscle while promoting fat loss in adults with obesity remains uncertain. We evaluated a CaHMB‐enriched nutritional supplement during energy restriction.
Jiaojiao Jiang   +5 more
wiley   +1 more source

Artificial Intelligence Techniques in Cardiac Neuromodulation: Mechanisms, Applications, and Pathways to Clinical Translation

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
Artificial intelligence could improve patient selection, stimulation control, and response monitoring in cardiac neuromodulation, yet direct clinical evidence remains scarce. We map available techniques onto these three challenges and argue that safe, adaptive closed‐loop control and established therapy efficacy are prerequisites for translation ...
Kshitiz Pandey   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy